AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04067219 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: DXA (dual-energy x-ray absorptiometric) measurement
Description: DXA, evaluation of muscular function and muscle strength; neurocognitive tests; non invasive analysis of mechanical skin properties; food frequency questionnaire; laboratory assessment (25 hydroxy vitamin D, calcium/phosphate metabolism, bone remodelling markers, T cell activation).
Study NCT02178241 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eribulin Mesylate
Description: Given IV
Study NCT02178241 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine Hydrochloride
Description: Given IV
Study NCT02334436 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Botulinum toxin, Type A
Description: Botulinum toxin, Type A
Study NCT02334436 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: 0.9% sterile, unpreserved saline
Description: Placebo Comparator Arm
Study NCT04962750 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Low level laser therapy
Description: Low level laser therapy from suitable machine
Study NCT04962750 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham device
Description: The device wasn't working
Study NCT02658240 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine
Description: Ropivacaine 300 mg and 0.5 mg epinephrine diluted to 60 mL
Study NCT03729934 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketone Ester
Description: This arm receives 25 g ketone ester.
Study NCT03729934 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketone Salt
Description: This arm receives 25 g ketone salt.
Study NCT03090997 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: vitamin C (500 mg / day) and resveratrol (500 mg / day)
Description: Adminstration of resveratrol (500 mg / day/orally) + vitamin C 500 mg/day/orally)
Study NCT01641133 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Synflorix (3-Dose)
Description: 3 doses administered intramuscularly
Study NCT01641133 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Synflorix (2-Dose)
Description: 2 doses administered intramuscularly
Study NCT01641133 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Synflorix (Single Dose)
Description: 1 dose administered intramuscularly
Study NCT01641133 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Prevenar 13 (Single Dose)
Description: 1 dose administered intramuscularly
Study NCT01641133 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Prevenar 13 (2-Dose)
Description: 2 doses administered intramuscularly
Study NCT00974961 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: bupivacaine, levobupivacaine
Description: intrathecal injection 15\~20mg(for Levobupivacaine) or 10\~15mg(for Bupivacaine) once
Study NCT02658240 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Epinephrine
Description: 0.5 mg epinephrine
Study NCT00993395 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: peer mentor-based disease management
Description: peer mentor-based disease management focused on three domains: medical care, recovery, and social stabilization
Study NCT01105221 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Participants, allocated to this group, will have twelve times of acupuncture treatment in four weeks. Seventeen acupuncture points, which are both BL2, GB14, TE23, Ex1, ST1, GB20, LI4, LI11 and single GV23, will be selected and disposable 0.20\*30mm acupuncture needles(Dongbang Co., Korea) will be inserted on these points. Strong 'deqi' sensation will be induced by twisting acupuncture needles and retained for 20 minutes before removed.
Study NCT01105221 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Refresh Plus
Description: Participants, allocated to this group, will be offered preservative-free and single-use Refresh plus (Sodium carboxymethylcellulose). They should use artificial tear in both eyes at least once a day for four weeks.
Study NCT04059406 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sapablursen
Description: sapablursen administered subcutaneously
Study NCT02021370 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BAY85-3934
Description: 25mg Tablet
Study NCT02021370 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching placebo tablet
Study NCT03960047 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Reality Training
Description: This group gets trained to cross streets using virtual reality
Study NCT03960047 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Streetside Training
Description: This group is trained to cross streets based on streetside experiences
Study NCT01402869 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 4% prilocaine plain
Description: 5mg/kg via infiltration into multiple sites of the buccal mucosa of mouth 1 time prior to start of restorative dental treatment
Study NCT01402869 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 2% Lidocaine with 1:100,000 epinephrine
Description: 2.5mg/kg via infiltration into multiple sites of buccal mucosa of mouth 1 time prior to restorative dental treatment
Study NCT00788814 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Pathways
Description: Strength-based curriculum addressing depression in women with with physical disabilities
Study NCT04326790 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Colchicine
Description: Low-dose colchicine treatment, 0.5 mg bid
Study NCT04326790 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard treatment
Description: Standard treatment
Study NCT04326790 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Standard treatment
Description: Standard treatment
Study NCT02991339 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone 10 mg iv for 2 days; then 5 mg iv for 1 day
Study NCT03649802 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Low dose vitamin D3
Description: Low dose arm-800 IU given daily
Study NCT03649802 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: High dose vitamin D3
Description: High dose arm-5000 IU given daily
Study NCT03070990 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enfortumab vedotin
Description: All subjects assigned will receive a single 30 minute intravenous infusion of enfortumab vedotin (ASG-22CE) once weekly for 3 weeks of every 4 weeks (i.e., on Days 1, 8, and 15). A cycle is 28 days.
Study NCT02962921 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin LISPRO intravenous loading
Description: intravenous infusion of insulin Lispro.
Study NCT02481258 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ataciguat (HMR1766)
Study NCT02481258 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator: Matching Placebo
Study NCT01402960 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High Definition Transcranial Direct Current Stimulation (HD-tDCS)
Description: Subject will receive active anodal/cathodal and sham HD-tDCS in a randomized, counterbalanced order. Each stimulation session will be separated by at least one week to avoid carryover effects. For both active and sham HD-tDCS the electrodes will be placed over the primary motor cortex, at an intensity of 2mA.~* For active anodal stimulation, the anode will be over the primary motor cortex, and the cathodal electrodes (4) will surround the anode in a 3 inch square, duration will be 20 minutes.~* For active cathodal stimulation, the cathode will be over the primary motor cortex, and the anodal electrodes (4) will surround the cathode in a 3 inch square, duration will be 20 minutes.~* For sham stimulation, the same procedure will be used, however, current will only be active for 30 seconds (current ramping up, then ramping down)
Study NCT01402960 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: High Definition Transcranial Direct Current Stimulation (HD-tDCS)
Description: Subject will receive active anodal/cathodal and sham HD-tDCS in a randomized, counterbalanced order. Each stimulation session will be separated by at least one week to avoid carryover effects. For both active and sham HD-tDCS the electrodes will be placed over the primary motor cortex, at an intensity of 2mA.~* For active anodal stimulation, the anode will be over the primary motor cortex, and the cathodal electrodes (4) will surround the anode in a 3 inch square, duration will be 20 minutes.~* For active cathodal stimulation, the cathode will be over the primary motor cortex, and the anodal electrodes (4) will surround the cathode in a 3 inch square, duration will be 20 minutes.~* For sham stimulation, the same procedure will be used, however, current will only be active for 30 seconds (current ramping up, then ramping down)
Study NCT02021370 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo tablet
Study NCT04247152 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Intraoperative Aberrometry vs preoperative biometry
Description: Hypothesis: Intraoperative aberrometry measures lower levels of astigmatism more accurately than preoperative biometry in patients undergoing cataract surgery.
Study NCT04053465 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Heat acclimation
Description: 14 days of aerobic exercise in a hot environment
Study NCT03132285 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: PrePex
Description: Prepex is a non surgical male circumcision device
Study NCT01027429 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: procaine penicillin and gentamicin
Description: procaine penicillin 50,000 units/kg by intramuscular injection once daily for 7 days; gentamicin, 5 mg/kg once daily by intramuscular injection for 7 days
Study NCT01027429 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: amoxicillin and gentamicin
Description: oral amoxicillin 80-90 mg/kg divided in two doses for 7 days intramuscular gentamicin, 5 mg/kg once daily for 7 days
Study NCT01027429 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: procaine penicillin, gentamicin, amoxicillin
Description: procaine penicillin, 50,000 IU/kg once daily intramuscular injection plus gentamicin 5 mg/kg once daily intramuscular injection for 2 days, followed by 5 days of oral amoxicillin, 80-90 mg/kg divided in two doses.
Study NCT01027429 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: procaine penicillin, gentamicin, amoxicillin
Description: procaine penicillin, 50,000 IU/kg once daily intramuscular injection plus gentamicin 5 mg/kg once daily intramuscular injection for 2 days, followed by 5 days of oral amoxicillin, 80-90 mg/kg divided in two doses.
Study NCT01070342 — intervention group
Intervention type: DEVICE
Intervention: Spacelabs 90217
Description: Comparison of the two ways to measure blood pressure: using the ambulatory blood pressure device (Spacelabs 90217) versus the standard method of measuring blood pressure is done by using a stethoscope and a blood pressure cuff.
Study NCT00611390 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: mixture of aromatic essential oils.
Description: 3% of mixture containing aromatic essential oils of Eucalyptus citriodora, Eucalyptus globulus, Mentha piperita, Origanum syriacum, and Rosmarinus Officinalis, spraying to the larynx.
Study NCT00611390 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: 0.1% of Lemon VIP (Florasynth,Israel), spraying to the larynx.
Study NCT02636647 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Fecal transplant
Study NCT03390725 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: A Healthy School Start Plus intervention
Description: Intervention for prevention of childhood overweight and obesity in disadvantaged areas through parental support in the school setting
Study NCT03390725 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: A Healthy School Start Plus intervention
Description: Intervention for prevention of childhood overweight and obesity in disadvantaged areas through parental support in the school setting
Study NCT04902209 — intervention group
Intervention type: PROCEDURE
Intervention: postural stability measurements
Description: Static balance assessment on bi-module stabilometric platform CQStab2P. It registers the movement of centre of foot pressure (COP).~Harris hip score- disability assesment
Study NCT00947219 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: HairMax LaserComb
Description: Device application 3 times week (non-consecutive days), for 26 weeks
Study NCT00947219 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Control device
Description: Device is used 3 times a week on non-consecutive days
Study NCT04063917 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ZENS
Description: ZENS transcutaneous nerve stimulator (ZENS Device), a wearable and non-invasive device which stimulates nerves in the neck to reduce airway obstruction and maintain muscular tension while sleeping to reduce snoring severity.
Study NCT03905915 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Virtual reality (VR) session with AQUA module
Description: A device with virtual reality is given to the patients with a film of 15 minutes
Study NCT03490929 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Intravenous Powder for Suspension [LUMASON]
Description: injection of Lumason (ultrasound contrast agent)
Study NCT03490929 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: contrast-enhanced ultrasound
Description: ultrasound of the abdomen after injection of ultrasound contrast agent (Lumason)
Study NCT03960684 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Levita Magnetic Surgical System
Description: Levita Magnetic Surgical System
Study NCT04053465 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Exercise in a cool environment
Description: 14 days of aerobic exercise in a cool environment
Study NCT04122001 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active, in-person HD-tDCS or active remote tDCS
Description: Stimulation will be delivered by a battery-driven constant current stimulator. The electrical current will be administered to a pre-specified region of the brain (angular gyrus). The stimulation will be delivered at an intensity of 2 milliamperes (mA) (estimated current density 0.04 mA/cm2; estimated total charge 0.048 Coulombs/cm2) in a ramp-like fashion for a maximum of 20 minutes. In the active, in-person HD-tDCS the current is delivered in a ring configuration. In the active remote tDCS current is delivered in one electrode patch.
Study NCT04122001 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham
Description: Current will be administered in a ramp-like fashion but after the ramping the intensity will drop to 0 mA. Current under the Sham condition will last for a maximum of 30 seconds.
Study NCT04122001 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Word List Learning Intervention (WordLLI)
Description: Participants will receive a word list learning intervention (WordLLI) of semantically related and unrelated word lists. Word lists are presented across 10 trials, with an additional trial after a 10-minute delay to assess delayed recall. Immediately following verbal presentation of word lists during each trial, participants will be instructed to recall as many of the words from the list as possible. Participants may use the written modality as a strategy during recall. Word lists include 12 words matched based on psycholinguistics attributes (e.g., imageability, frequency). This task is designed to help participants improve memory via enhancing list learning capabilities.
Study NCT03761056 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Axicabtagene Ciloleucel
Description: A single infusion of chimeric antigen receptor (CAR)-transduced autologous T cells
Study NCT03761056 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Administered according to package insert
Study NCT03761056 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Administered according to package insert
Study NCT06716866 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: temporally-interfering electric field stimulation
Description: Temporally-interfering electric field stimulation is a candidate non-invasive means to stimulate and modulate the nervous system. We do not know of any other trials of this method in epilepsy patients.
Study NCT00402415 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sunitinib malate
Description: C1: 50 mg po days 1-15, 2 weeks off C2: 50 mg po x 4 weeks, 2 weeks off
Study NCT00402415 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rapamycin
Description: Dose escalation until MTD as follows:~C1: not given C2: 4 mg weekly, 8 mg weekly, 12 mg weekly, 20 mg weekly
Study NCT00713323 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sativex®
Description: containing THC (27 mg/ml):CBD (25 mg/ml), in ethanol:propylene glycol (50:50) excipients, with peppermint oil (0.05%) flavouring. Maximum permitted dose was eight actuations in any three hour period and 24 actuations (THC 65 mg: CBD 60 mg) in 24 hours
Study NCT00631995 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Meningococcal Polysaccharide Tetanus Protein Conjugate
Description: 0.5 mL, Intramuscular
Study NCT01894464 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Teacher led intervention
Study NCT04167254 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sit Down and Play
Description: Brief health care-based program that aims to promote key parenting behaviors that promote early childhood development
Study NCT05227976 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Patient education (Theory)
Description: Theory/Lectures (1h/week)~Interventions given once weekly for 10 weeks.
Study NCT05227976 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physical training
Description: Physical training group (1 hour/week)~Interventions given once weekly for 10 weeks.
Study NCT05227976 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindfulness and medical yoga in group
Description: Mindfulness/medical yoga in group (1hour/week)~Interventions given once weekly for 10 weeks.
Study NCT00631995 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Meningococcal polysaccharide group C conjugated
Description: 0.5 mL, Intramuscular
Study NCT04195087 — intervention group
Intervention type: DEVICE
Intervention: Masimo Radical-7® Pulse CO-Oximeter®
Description: The perfusion index and Pleth variability index will be recorded from the device monitor.
Study NCT03898284 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Impulse Oscillometry
Description: Impulse Oscillometry will be performed in addition to usual care
Study NCT03672214 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Without placement of indwelling catheter
Description: No placement of indwelling catheter prior to Caesarean section
Study NCT03672214 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: With placement of indwelling catheter
Description: Placement of indwelling catheter prior to Caesarean section
Study NCT02922192 — intervention group
Intervention type: DRUG
Intervention: TNF-α antagonists, non-TNFs, DMARD non-biologics
Description: Exposure to TNF- α antagonists, non-TNF- α antagonists, oral DMARD, or non-biologic agents.
Study NCT03910621 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Miglustat
Description: capsule, oral use
Study NCT04632017 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Computerized cardiotocography
Description: To compare Dawes and Redman indices as determined by computer analysis of the fetal heart tracing
Study NCT00022152 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: vinorelbine tartrate
Study NCT01085526 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Alutard phleum pratense subcutaneous immunotherapy
Description: standard regimen of SCIT
Study NCT01085526 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Alutard phl prat
Study NCT02136225 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Means restriction counseling
Description: Health care providers will counsel parents on the risks of having a gun, particularly an unlocked gun, in the home where youth are present.
Study NCT03693495 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ellume·lab Group A Streptococcus Test
Description: ellume.lab Group A Streptococcus Test is a rapid diagnostic test intended to be used as an aid in the diagnosis of Group A Streptococcus in symptomatic participants. The sample type used is a throat swab.
Study NCT03693495 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Bacterial Culture
Description: Pharyngeal swab is collected from participant and this specimen is inoculated into 5% sheep blood agar plates. Beta-haemolytic colonies are isolated, followed by latex agglutination test.